-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QCx7mf0G6Gf04yZEf0tOmc67ptEaecZGHArxeYU/glTnEdDiNzlXYfBcZOUvBrlv LAXGhfZyQ9OzZdohGoGvhw== 0000950123-10-071902.txt : 20100804 0000950123-10-071902.hdr.sgml : 20100804 20100803174825 ACCESSION NUMBER: 0000950123-10-071902 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100630 FILED AS OF DATE: 20100804 DATE AS OF CHANGE: 20100803 EFFECTIVENESS DATE: 20100804 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BB BIOTECH AG CENTRAL INDEX KEY: 0000924223 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-06964 FILM NUMBER: 10988742 BUSINESS ADDRESS: STREET 1: VODERGASSE 3 STREET 2: SWITZERLAND CITY: SCHAFFHAUSEN STATE: V8 ZIP: CH-8300 BUSINESS PHONE: 411724 59 59 MAIL ADDRESS: STREET 1: VODERGASSE 3 STREET 2: SWITZERLAND CITY: SCHAFFHAUSEN STATE: V8 ZIP: CH-8300 13F-HR 1 w79353be13fvhr.txt 13F-HR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for Calendar Year or Quarter Ended: June 30, 2010 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: BB Biotech AG Address: Vordergasse 3 Schaffhausen Switzerland CH-8200 Form 13F File Number: 28-6964 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Pascal Schmucki Title: SIGNING AUTHORITY Phone: 41 (44) 267 67 00 Signature, Place, and Date of Signing: /s/ Pascal Schmucki ----------------------------------------- Schaffhausen, Switzerland, August 2, 2010 Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) 1 Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 3 Form 13F Information Table Entry Total: 18 Form 13F Information Table Value Total: $848,039 --------- (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. No. Form 13F File Number Name - --- -------------------- ---- 1 28-11193 Biotech Focus N.V. 2 28-11191 Biotech Invest N.V. 3 28-11189 Biotech Target N.V. 2 BB BIOTECH AG FORM 13F INFORMATION TABLE
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 -------- -------- -------- -------- ------------------ ---------- -------- --------------------- VOTING AUTHORITY TITLE OF VALUE SHS OR SH/ PUT/ INVESTMENT OTHER --------------------- NAME OF ISSUER CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE -------------- -------- --------- -------- --------- --- ---- ---------- -------- --------- ------ ---- Affymetrix Inc COM 00826T108 11,800 2,000,000 SH DEFINED 1 2,000,000 NONE NONE Alexion Pharmaceuticals Inc COM 015351109 16,637 325,000 SH DEFINED 2 325,000 NONE NONE Amgen Inc COM 031162100 26,300 500,000 SH DEFINED 1 500,000 NONE NONE Arena COM 040047102 16,676 5,431,980 SH DEFINED 3 5,431,980 NONE NONE Pharmaceuticals Inc Biogen Idec Inc COM 09062X103 7,744 163,200 SH DEFINED 1 163,200 NONE NONE Biomarin Pharmaceutical Inc COM 09061G101 16,533 871,983 SH DEFINED 2 871,983 NONE NONE Celgene Corp COM 151020104 221,801 4,364,439 SH DEFINED 2 4,364,439 NONE NONE Elan Corp ADR 284131208 6,750 1,500,000 SH DEFINED 2 1,500,000 NONE NONE Genzyme Corp COM 372917104 25,720 506,600 SH DEFINED 1 506,600 NONE NONE Gilead Sciences Inc COM 375558103 192,474 5,614,768 SH DEFINED 1 5,614,768 NONE NONE Halozyme Therapeutics Inc COM 40637H109 1,374 195,100 SH DEFINED 3 195,100 NONE NONE Idenix Pharmaceuticals Inc COM 45166R204 1,546 309,235 SH DEFINED 3 309,235 NONE NONE Immunogen COM 45253H101 32,653 3,522,478 SH DEFINED 3 3,522,478 NONE NONE Incyte Corp COM 45337C102 32,970 2,978,300 SH DEFINED 3 2,978,300 NONE NONE Micromet Inc COM 59509C105 34,926 5,597,101 SH DEFINED 3 5,597,101 NONE NONE Optimer Pharmaceuticals Inc COM 68401H104 14,102 1,521,303 SH DEFINED 3 1,521,303 NONE NONE Vertex COM 92532F100 158,493 4,817,408 SH DEFINED 3 4,817,408 NONE NONE Pharmaceuticals Inc Zymogenetics Inc COM 98985T109 29,540 7,000,000 SH DEFINED 3 7,000,000 NONE NONE
3 -----END PRIVACY-ENHANCED MESSAGE-----